Urinary 6β-hydroxycortisol and D-glucaric acid exrection rates are not affected by lansoprazole treatment

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 1, 1997, Pages 14-18

  Rost, K L ^a,c   Mansmann, U ^a   Roots, I ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c DRK KLINIKEN BERLIN WESTEND   (Germany)

Author keywords

6 hydroxycortisol; Cytochrome p450; D glucaric acid; Enzyme induction; Lansoprazole; Oral contraceptives

Indexed keywords

6BETA HYDROXYHYDROCORTISONE; CYTOCHROME P450; ETHINYLESTRADIOL PLUS LEVONORGESTREL; LANSOPRAZOLE; ORAL CONTRACEPTIVE AGENT; PHENOBARBITAL; SACCHARIC ACID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; LIVER CELL; MENSTRUAL CYCLE; MENTAL DISEASE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; CONTRACEPTIVES, ORAL, COMBINED; CROSS-OVER STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME INDUCTION; ENZYME INHIBITORS; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; FEMALE; GLUCARIC ACID; HUMANS; HYDROCORTISONE; LEVONORGESTREL; OMEPRAZOLE; PLACEBOS; PROGESTERONE CONGENERS;

EID: 0031015868     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Campbell ME, Spielberg SP, Kalow W 1987 A urinary metabolite ratio that reflects systemic caffeine clearance. Clin Pharmacol Ther 42: 157-165
2. Colombi A, Maroni M, Antonini C, Fait A, Zocchetti C, Foa V 1983 Influence of sex, age, and smoking habits on the urinary excretion of D-glucaric acid. Clin Chim Acta 128: 349-358
3. Curi-Pedrosa R, Daujat M, Pichard L, Ourlin JC, Clair P, Gervot L, Lesca P, Domergue J, Joyeux H, Fourtanier G, Maurel P 1994 Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. J Pharmacol Exp Ther 269: 384-392
4. Frantz AG, Katz FH, Jailer JW 1961 6-β-hydroxycortisol and other polar corticosteroids; measurements and significance in human urine. J Clin Endocrinol Metab 21: 1290-1303
5. Fuchs W, Sennewald R, Klotz U 1994 Lansoprazole does not affect the bioavailabuity of oral contraceptives. Br J Clin Pharmacol 38: 376-380
6. Ged C, Rouillon JM, Pichard L, Combalbert J, Bressot N, Bories P, Michel H, Beaune P, Maurel P 1989 The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Pharmacol 28: 373-387
7. Guengerich FP 1988 Oxidation of 17β-ethinylestradiol by human liver cytochrome P450. Mol Pharmacol 33: 500-508
8. Harmsworth WL, Franklin MR 1990 Induction of hepatic and extrahepatic cytochrome P-450 and monooxygenase activities by N-substituted imidazoles. Xenobiotica 20: 1053-1063
9. Heinemeyer G, Roots I, Lestau P, Klaiber HR, Dennhardt R 1986 D-Glucaric acid excretion in critical care patients - comparison with 6β-hydroxycortisol excretion and serum γ-glutamyltranspeptidase activity and relation to multiple drug therapy. Br J Clin Pharmacol 27:9-18
10. Hildebrandt AG, Roots I, Speck M, Saalfrank K, Kewitz H 1975 Evaluation of in vivo parameters of drug-metabolizing enzyme activity in man after administration of clemastine, phenobarbital or placebo. Eur J Clin Pharmacol 8: 327-336
11. Hunter J, Maxwell JD, Carrella M, Stewart DA, Williams R 1971 Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man. Lancet I: 572-575
12. Jones B, Kenward MG 1989 Design and Analysis of Cross-Over Trials. Chapman and Hall, London
13. Kampf D, Roots I, Hildebrandt AG 1980 Urinary excretion of D-glucaric acid, an indicator of drug-metabolizing enzyme activity, in patients with impaired renal function. Eur J Clin Pharmacol 18: 255-261
14. Knodell RG, Browne DG, Gwozdz GP, Brian WR, Guengerich FP 1990 Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 101: 1680-1691
15. Kuhnz W, Lofberg B 1995 Urinary excretion of 6 beta-hydroxycortisol in women during treatment with different oral contraceptive formulations. J Steroid Biochem Mol Biol 55: 129-133
16. Marsh CA 1963 Metabolism of D-glucuronolactone in mammalian systems. Identification of D-glucaric acid as a normal constituent of urine. Biochem J 86: 77-86
17. Martucci C, Fishman J 1993 P450 enzymes of estrogen metabolism. Pharmacol Ther 57: 237-257
18. Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, Maurel P 1992 Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J 6: 752-758
19. Marita K, Konishi H, Shimakawa H 1992 Fluconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in mice and humans in vivo. Comparative study with ketoconazole. Chem Pharm Bull Tokyo 40: 1247-1251
20. Mowat AP 1968 Developmental effects on liver D-glucuronolactone dehydrogenase levels and on D-glucaric acid excretion in urine; hormonal effects on D-glucaric acid excretion in urine. J Endocrinol 42: 585-590
21. Nakamura J, Yakata M 1985 Age-and sex-related differences in urinary excretion of 6β-hydroxycortisol in humans. Clin Chim Acta 752: 193-197
22. Ohnhaus EE, Park BK 1979 Measurement of urinary 6β-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur J Clin Pharmacol 15: 139-145
23. O'Malley K, Stevenson IH, Crooks J 1972 Impairment of human drug metabolism by oral contraceptive steroids. Clin Pharmacol Ther 13: 552-557
24. Reill L, Erhardt F, Rost KL, Roots I, Fischer R, Londong W 1993 Effect of oral pantoprazole on 24-hour intragastric pH, serum gastrin profile and drug metabolizing enzyme activity in man - a placebo-controlled comparison with ranitidine. Gut 34 (Suppl 4): 63
25. Roots I, Holbe R, Hövermann, Nigam S, Heinemeyer G, Hildebrandt AG 1979 Quantitative determination by HPLC of urinary 6β-hydroxy-cortisol, an indicator of enzyme induction by rifampicin and antiepileptic drugs. Eur J Clin Pharmacol 16: 63-71
26. 13C-(N-3-methyl)-caffeine breath test in poor and extensive metabolizers of S-mephenytoin. Clin Pharmacol Ther 52: 170-180
27. Rost KL, Brösicke H, Heinemeyer G, Roots I 1994 Specific and dose-dependent enzyme induction by omeprazole in human beings. Hepatology 20: 1204-1212
28. Schuirmann DJ 1987 A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokin Biopharm 15: 657-680
29. Stevens PM, Vose CW, Palmer RF 1978 Urinary D-glucaric acid and oral contraceptives. Br J Clin Pharmacol 5: 535-536
30. Walaszek Z, Szemraj J, Hanusek M, Adams AK, Sherman U 1996 D-glucaric acid content of various fruits and vegetables and cholesterollowering effects of dietary D-glucarate in the rat. Nutrition Res 76: 673-681
31. Waxman DJ, Attisano C, Guengerich FP, Lapenson DP 1988 Human liver microsomal steroid metabolism; identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys 263: 424-436